Chengdu Guowei Biopharmaceutical

Chengdu Guowei Biopharmaceutical is a Chinese biotechnology company specializing in the research, development, and large-scale production of human vaccines. The company is primarily recognized for its Human Rabies Vaccine (Human Diploid Cell), which utilizes advanced cell culture technology to provide a safer and more immunogenic alternative to traditional Vero cell-based vaccines. Headquartered in the Wenjiang District of Chengdu, Guowei operates within the Sichuan provincial bio-industry cluster and maintains state-of-the-art GMP-certified manufacturing facilities. Their business model focuses on addressing the high demand for premium biological products in the Chinese domestic market. By successfully commercializing human diploid cell technology, the company has established itself as a key player in the specialized rabies prevention sector.